Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Global Smart Hospitals Market to Reach $111.2 Billion by 2026

Published

on

New York, Nov. 05, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Smart Hospitals Industry” – https://www.reportlinker.com/p05960080/?utm_source=GNW
Digitization helps by interconnecting all hospital assets, helping smart hospitals achieve greater operational efficiency and experience, and deliver improved patient care. The smart set-up adds three important elements in the form of data, access and insight to hospitals that helps enhance the quality of care. With artificial intelligence, data collection and automation deeply ingrained in new smart hospital set-ups, almost everyone including physicians, nursing staff, support staff and patients stand to gain. Smart hospitals require continued team work where physicians, nursing staff and management need to work together to swiftly detect any potential problems so that relevant solutions are quickly identified, piloted and implemented. This would ensure clinical processes, care quality, patient experience remain uncompromised, while the hospital reaps optimal operational efficiency and keeps cost under control.

Amid the COVID-19 crisis, the global market for Smart Hospitals estimated at US$30.1 Billion in the year 2020, is projected to reach a revised size of US$111.2 Billion by 2026, growing at a CAGR of 23.4% over the analysis period. Services, one of the segments analyzed in the report, is projected to grow at a 22.3% CAGR to reach US$73.6 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hardware segment is readjusted to a revised 23.8% CAGR for the next 7-year period. This segment currently accounts for a 23.9% share of the global Smart Hospitals market.

The U.S. Market is Estimated at $10.9 Billion in 2021, While China is Forecast to Reach $15.2 Billion by 2026

The Smart Hospitals market in the U.S. is estimated at US$10.9 Billion in the year 2021. The country currently accounts for a 29.46% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$15.2 Billion in the year 2026 trailing a CAGR of 26.9% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 19.8% and 22.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 21.9% CAGR while Rest of European market (as defined in the study) will reach US$18.4 Billion by the close of the analysis period.

The exponential growth of COVID-19 cases globally has resulted in tremendous burden on hospitals and medical staff. The situation has prompted various healthcare facilities to rely on artificial intelligence (AI) based sensors for supporting triage in effective manner. The scenario has also led various companies to leverage AI for developing contactless infrared sensor devices for identifying people with a fever in crowds. These devices are being increasingly deployed by hospitals for replacing manual screening options to reduce unnecessary exposure of the medical staff to COVID-19 patients. Various hospitals have implemented AI systems for intercepting individuals with specific COVID-19 symptoms among visiting patients. The technology relies on cameras deployed at entrances for conducting facial thermal scans and identifying infected patients on the basis of specific signs such as discoloration and sweat. In addition to screening, the AI technology is used for monitoring patient symptoms, offering decision support related to CT scans and automating hospital operations. Certain healthcare facilities have also deployed AI-powered robots that can deal with patients and offer minor treatments. Smart robots intended to deliver foods or medicines to patients reduce physician exposure to infected people.

Systems & Software Segment to Reach $21.2 Billion by 2026

In the global Systems & Software segment, USA, Canada, Japan, China and Europe will drive the 26% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.8 Billion in the year 2020 will reach a projected size of US$19.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.3 Billion by the year 2026.
Select Competitors (Total 46 Featured)

  • AdhereTech Inc.
  • Capsule Technologies, Inc.
  • Cerner Corporation
  • GE Healthcare
  • Honeywell International Inc.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Medtronic plc
  • SAP SE
  • Siemens AG
  • STANLEY Healthcare

Read the full report: https://www.reportlinker.com/p05960080/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Rise of IT in Healthcare Provides the Cornerstone for the
Growth of Smart Hospitals
EXHIBIT 1: Global Spending on Healthcare IT (In US$ Billion)
for Years 2018, 2020, 2022 and 2024
The Race Between the Virus & Vaccines Intensifies. Amidst this
Chaotic Battle, Where is the World Economy Headed in 2021?
These are Times When Questions Abound & Answers Are Few
So How Fast Or Slow Are We Moving?
EXHIBIT 2: How Fast the World is Vaccinated Will Determine How
Soon the Pandemic Will End: Global Number of Annual COVID-19
Vaccine Doses (In Million) for Years 2020 through 2025 by
Geographic Region/Country
Progress on Vaccinations, Why Should Businesses Care?
As India Burns Amid a Lethal Double & Triple Mutation Driven
Second Wave, Its Clear That Equity is Not a Part of Global
Policy on Tackling COVID
EXHIBIT 3: What We Know So Far – ?Vaccine Efficiency Against
New Strains is Decreasing?
With IMF?s Upward Revision of Global GDP Forecasts for 2021,
Most Companies Are Bullish About a Global Economic Comeback
EXHIBIT 4: A Strong 2021 Economic Rebound Based On Pent-Up
Demand Comes as a Relief for Suffering Industries & Markets:
World Economic Growth Projections (Real GDP, Annual % Change)
for 2020 through 2022
EXHIBIT 5: Easing Unemployment Levels in 2021 Although Moderate
Will Infuse Hope for Industries Reliant on Consumer
Discretionary Incomes: Global Number of Unemployed People (In
Million) for Years 2019, 2020, 2021, and 2022
A Retrospective Review of Year 2020 as the Worst Year in
Humanity?s History that Left the World in Shambles &
Industries and Markets Upended
How the Healthcare Industry Has & Continues to be Impacted by
the Pandemic & What?s the New Normal?
The Biggest & Worst Ever Public Health Crisis in Human History
Creates a Mixed Bag of Challenges & Opportunities for the
Healthcare Industry
EXHIBIT 6: With the COVID-19 Pandemic Exposing Global
Healthcare Unpreparedness, There is Increasing Policy Led
Focus on Rebooting Health Systems Worldwide: Current &
Required Healthcare Spending as % of GDP
Clinical Diagnostic Laboratories Work Overtime to Manage Giant
Waves of COVID Infection Testing Flowing In
EXHIBIT 7: Global Clinical Diagnostics Market Reset &
Trajectory – Growth Outlook (In %) For Years 2019 Through 2025
The Pandemic Triggers Shift in Consumer Behavior & Engagement
With Healthcare Technologies & Services
Healthcare Industry Pushed to Adopt Digital Technologies &
Innovate to Save Lives Amid the Crisis
EXHIBIT 8: Digital Health Technologies Poised to Break New
Grounds Post Pandemic: Global Opportunity in Digital Health:
(In US$ Billion) for Years 2020, 2022, 2024 and 2026
Smart Hospitals, What Are They & Why Are they the Future of
Healthcare
Recent Market Activity
Innovations

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
COVID-19 Accelerates the Shift to Smart Hospitals. Here?s Why
RFID Based Smart Hospital Asset Tracking & Management Gains in
Prominence
Medical Robots Emerge to Make Hospitals Smart & Efficient
EXHIBIT 9: Number of Surgical Robots Deployed by Hospitals
Worldwide (In Units) for Years 2017, 2019, 2022, 2024 & 2026
Smart Hospitals Step Up the Use of VR simulations to Train
Medical Personnel
Growing Deployment of Connected Medical Devices Across
Healthcare Enable the Creation of Smart Hospitals
Emergence of AI-Enabled Smart Hospitals to Transform Patient
Experience and Improve Medical Outcomes
As Smart Hospitals Become Popular, Cybersecurity Storms Into
the Spotlight

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Smart Hospitals by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Revenues in US$ Million for Years 2020 through 2027
and % CAGR

Table 2: World 7-Year Perspective for Smart Hospitals by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Services by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Revenues in US$ Million for Years 2020 through 2027
and % CAGR

Table 4: World 7-Year Perspective for Services by Geographic
Region – Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
for Years 2020 & 2027

Table 5: World Current & Future Analysis for Hardware by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Revenues in US$ Million for Years 2020 through 2027
and % CAGR

Table 6: World 7-Year Perspective for Hardware by Geographic
Region – Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
for Years 2020 & 2027

Table 7: World Current & Future Analysis for Systems & Software
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Revenues in US$ Million for Years 2020 through 2027
and % CAGR

Table 8: World 7-Year Perspective for Systems & Software by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Remote Medicine
Management by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Revenues in US$ Million for Years 2020
through 2027 and % CAGR

Table 10: World 7-Year Perspective for Remote Medicine
Management by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

Table 11: World Current & Future Analysis for Electronic Health
Record & Clinical Workflow by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Revenues in US$ Million for
Years 2020 through 2027 and % CAGR

Table 12: World 7-Year Perspective for Electronic Health Record &
Clinical Workflow by Geographic Region – Percentage Breakdown
of Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 13: World Current & Future Analysis for Medical
Assistance by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Revenues in US$ Million for Years 2020
through 2027 and % CAGR

Table 14: World 7-Year Perspective for Medical Assistance by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 15: World Current & Future Analysis for Outpatient
Vigilance by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Revenues in US$ Million for Years 2020
through 2027 and % CAGR

Table 16: World 7-Year Perspective for Outpatient Vigilance by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 17: World Current & Future Analysis for Medical Connected
Imaging by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Revenues in US$ Million for Years 2020
through 2027 and % CAGR

Table 18: World 7-Year Perspective for Medical Connected
Imaging by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 19: USA Current & Future Analysis for Smart Hospitals by
Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 20: USA 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 21: USA Current & Future Analysis for Smart Hospitals by
Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 22: USA 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

CANADA
Table 23: Canada Current & Future Analysis for Smart Hospitals
by Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 24: Canada 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 25: Canada Current & Future Analysis for Smart Hospitals
by Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 26: Canada 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

JAPAN
Table 27: Japan Current & Future Analysis for Smart Hospitals
by Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 28: Japan 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 29: Japan Current & Future Analysis for Smart Hospitals
by Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 30: Japan 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

CHINA
Table 31: China Current & Future Analysis for Smart Hospitals
by Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 32: China 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 33: China Current & Future Analysis for Smart Hospitals
by Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 34: China 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

EUROPE
Table 35: Europe Current & Future Analysis for Smart Hospitals
by Geographic Region – France, Germany, Italy, UK and Rest of
Europe Markets – Independent Analysis of Annual Revenues in US$
Million for Years 2020 through 2027 and % CAGR

Table 36: Europe 7-Year Perspective for Smart Hospitals by
Geographic Region – Percentage Breakdown of Value Revenues for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2020 & 2027

Table 37: Europe Current & Future Analysis for Smart Hospitals
by Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 38: Europe 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 39: Europe Current & Future Analysis for Smart Hospitals
by Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 40: Europe 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

FRANCE
Table 41: France Current & Future Analysis for Smart Hospitals
by Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 42: France 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 43: France Current & Future Analysis for Smart Hospitals
by Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 44: France 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

GERMANY
Table 45: Germany Current & Future Analysis for Smart Hospitals
by Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 46: Germany 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 47: Germany Current & Future Analysis for Smart Hospitals
by Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 48: Germany 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

ITALY
Table 49: Italy Current & Future Analysis for Smart Hospitals
by Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 50: Italy 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 51: Italy Current & Future Analysis for Smart Hospitals
by Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 52: Italy 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

UNITED KINGDOM
Table 53: UK Current & Future Analysis for Smart Hospitals by
Component – Services, Hardware and Systems & Software –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 54: UK 7-Year Perspective for Smart Hospitals by
Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 55: UK Current & Future Analysis for Smart Hospitals by
Application – Remote Medicine Management, Electronic Health
Record & Clinical Workflow, Medical Assistance, Outpatient
Vigilance and Medical Connected Imaging – Independent Analysis
of Annual Revenues in US$ Million for the Years 2020 through
2027 and % CAGR

Table 56: UK 7-Year Perspective for Smart Hospitals by
Application – Percentage Breakdown of Value Revenues for Remote
Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

REST OF EUROPE
Table 57: Rest of Europe Current & Future Analysis for Smart
Hospitals by Component – Services, Hardware and Systems &
Software – Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR

Table 58: Rest of Europe 7-Year Perspective for Smart Hospitals
by Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 59: Rest of Europe Current & Future Analysis for Smart
Hospitals by Application – Remote Medicine Management,
Electronic Health Record & Clinical Workflow, Medical
Assistance, Outpatient Vigilance and Medical Connected Imaging –
Independent Analysis of Annual Revenues in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 60: Rest of Europe 7-Year Perspective for Smart Hospitals
by Application – Percentage Breakdown of Value Revenues for
Remote Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

ASIA-PACIFIC
Table 61: Asia-Pacific Current & Future Analysis for Smart
Hospitals by Component – Services, Hardware and Systems &
Software – Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR

Table 62: Asia-Pacific 7-Year Perspective for Smart Hospitals
by Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 63: Asia-Pacific Current & Future Analysis for Smart
Hospitals by Application – Remote Medicine Management,
Electronic Health Record & Clinical Workflow, Medical
Assistance, Outpatient Vigilance and Medical Connected Imaging –
Independent Analysis of Annual Revenues in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 64: Asia-Pacific 7-Year Perspective for Smart Hospitals
by Application – Percentage Breakdown of Value Revenues for
Remote Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

REST OF WORLD
Table 65: Rest of World Current & Future Analysis for Smart
Hospitals by Component – Services, Hardware and Systems &
Software – Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR

Table 66: Rest of World 7-Year Perspective for Smart Hospitals
by Component – Percentage Breakdown of Value Revenues for
Services, Hardware and Systems & Software for the Years 2020 &
2027

Table 67: Rest of World Current & Future Analysis for Smart
Hospitals by Application – Remote Medicine Management,
Electronic Health Record & Clinical Workflow, Medical
Assistance, Outpatient Vigilance and Medical Connected Imaging –
Independent Analysis of Annual Revenues in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 68: Rest of World 7-Year Perspective for Smart Hospitals
by Application – Percentage Breakdown of Value Revenues for
Remote Medicine Management, Electronic Health Record & Clinical
Workflow, Medical Assistance, Outpatient Vigilance and Medical
Connected Imaging for the Years 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 46
Read the full report: https://www.reportlinker.com/p05960080/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

MediaGo Honored as Gold Stevie® Award winner in 2024 American Business Awards®

Published

on

mediago-honored-as-gold-stevie-award-winner-in-2024-american-business-awards

MediaGo recognized for its deep learning technology and SmartBid product
SAN FRANCISCO, May 2, 2024 /PRNewswire/ — MediaGo, a deep learning-based intelligent advertising platform under the umbrella of Baidu Global, was named the winner of a Gold Stevie® Award in the 22nd Annual American Business Awards® for the second consecutive year – this time in the Marketing/Public Relations Solution category.

Recognized for setting a new standard in the industry for campaign performance and efficiency, MediaGo leverages Baidu’s underlying artificial intelligence (AI) technology and deep learning algorithms to empower businesses of all scales, creating tangible value for companies. With 12 operation centers worldwide, MediaGo has successfully provided localized and comprehensive business growth services to over 10,000 partners.
The American Business Awards are the U.S.A.’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations – public and private, for profit and non-profit, large and small. More than 3,700 nominations from organizations of all sizes were submitted this year for consideration.
When assessing MediaGo’s entry, American Business Awards judges noted that MediaGo’s “innovative use of deep learning in advertising optimization represents a significant leap forward, yielding tangible benefits for advertisers, including increased conversion rates and reduced costs per action. The significant enhancements to SmartBid technology, evidenced by substantial increases in campaign performance and efficiency, set a new standard in the industry.”
MediaGo’s SmartBid product is built on a deep neural network of over 1 billion parameters. Leveraging big data analytics and deep learning algorithms, MediaGo’s SmartBid predicts the likelihood of user conversions and adjusts the baseline bid accordingly. Furthermore, SmartBid capabilities automatically self-adjust to improve ad performance based on historical and real-time data, optimizing the advertisers’ return on investment.
“Our SmartBid product has proved itself by continuously providing substantial value to advertisers worldwide,” says Rena Ren, Americas Regional Director of Baidu Global Business Unit. “MediaGo strives to help advertisers reach their goals with easy-to-use, effective technology. Being recognized by a premier organization like the American Business Awards reaffirms our belief. ”
About MediaGo
MediaGo is an intelligent advertising platform under the umbrella of Baidu Global. Leveraging Baidu’s underlying AI technology and based on deep learning algorithms, MediaGo empowers businesses of all scales, creating tangible value for companies. With 12 operational centers worldwide, MediaGo has successfully provided localized and comprehensive business growth services to over 10,000 partners.
Learn more about MediaGo at https://www.mediago.com/.
Photo – https://mma.prnewswire.com/media/2401304/2024_MediaGo_ABA_Banner.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/mediago-honored-as-gold-stevie-award-winner-in-2024-american-business-awards-302131655.html

Continue Reading

Artificial Intelligence

Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success

Published

on

clarivate-enhances-cortellis-cmc-intelligence-with-post-approval-module-to-accelerate-regulatory-success

Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics 
LONDON, May 2, 2024 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking. With this update, pharmaceutical, biotech, and generics companies can effortlessly navigate the regulatory process and prioritize essential actions.

CMC activities account for nearly 18% of the entire R&D budget, emphasizing the importance of optimization and validation. Cortellis CMC Intelligence for post-approval variations enables clients to compare requirements across 64 countries, reducing tracking time and increasing submission rates with organized, timely, and accurate information.
Justin Hubbard, Vice President, Product Management, Life Sciences & Healthcare, Clarivate, said: “This enhancement underscores our commitment to simplifying the complexities of CMC regulatory dossier submissions for our clients. By offering transformative insights, Clarivate accelerates their path to markets and patients. With the ability to efficiently compare regulations across countries for small molecules and biologics, as well as automate CMC regulatory monitoring through user-configured alerts, clients can navigate the process with confidence.” 
With its new module covering both pre- and post-approval documents, Cortellis CMC Intelligence offers comprehensive lifecycle information for drugs and biologics. Serving as a single-platform solution for CMC requirements, it effectively reduces tracking time and unnecessary costs.
About Cortellis CMC Intelligence
Cortellis CMC Intelligence curates and tracks official CMC regulations and local practices for more than 135+ countries, territories and organizations for small molecules and 64 countries, territories and regions for biologics, with pre-and post-approval module coverage. Robust data is available for 25+ product and regulatory-related filters based on eCTD structure, including 6K+ source documents and over 2K links to Cortellis Regulatory Intelligence, providing access to expanded detail and in-depth summaries from experts in local regulatory practices, paired with reference source documents, to offer a complete picture. The addition of a new post-approval module now makes a comprehensive CMC solution with complete lifecycle information for drugs and biologics to increase submission rates and avoid costly delays. To learn more about Cortellis CMC Intelligence, visit here.
About ClarivateClarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com 
Media Contact:Luna IvkovicExternal Communications, Life Sciences & [email protected]
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-enhances-cortellis-cmc-intelligence-with-post-approval-module-to-accelerate-regulatory-success-302133824.html

Continue Reading

Artificial Intelligence

Permira to Acquire Majority Position in BioCatch at $1.3bn Valuation

Published

on

permira-to-acquire-majority-position-in-biocatch-at-$1.3bn-valuation

Permira Growth Opportunities Transaction builds on initial minority investment made in early 2023 to acquire a majority position and support BioCatch’s accelerated growth within online fraud detection and financial crime prevention
NEW YORK and TEL AVIV, Israel, May 2, 2024 /PRNewswire/ — BioCatch (the “Company”), the global leader in digital fraud detection and financial crime prevention powered by behavioral biometric intelligence, today announced that Permira Growth Opportunities II (the “Fund”), a fund advised by global private equity firm Permira, has agreed to acquire a majority position in the Company. Alongside the Fund’s investment, existing shareholders Sapphire Ventures and Macquarie Capital will also increase their investments in BioCatch. The transaction is expected to accelerate the Company’s global expansion, advance its innovative product roadmap and support its continued overall growth.

Under the terms of the agreement, the Fund will acquire a majority stake in BioCatch, buying out shares primarily from Bain Capital Tech Opportunities and Maverick Ventures, in a secondary transaction valuing the Company at a total enterprise valuation of $1.3bn.
BioCatch was founded in 2011 – at the dawn of a significant consumer shift from branch to online banking – with a mission to fight fraud and keep users safe in online transactions without disrupting user experience. Today, the Company is a leader in behavioral biometric intelligence and advanced fraud detection, leveraging patented artificial intelligence, data science, and machine learning technology to analyze a user’s cognitive intent and deliver highly accurate insights as to the legitimacy of their identity, motivations, and behavior. In 2023, the Company expanded its mission to include a proactive approach to fighting financial crime with the launch of predictive, behavior-based mule account detection.
As fraud attacks have become increasingly scaled, sophisticated and complex, BioCatch has experienced significant and sustained momentum. Permira, via its growth equity strategy, completed an initial minority investment in the Company in early 2023, a year that BioCatch ultimately finished with 49% ARR growth, whilst also surpassing the $100 million ARR milestone and attaining EBITDA profitability. Today, BioCatch counts more than 190 financial institutions as customers globally, including over 30 of the world’s largest 100 global banks, who use its solutions to fight fraud, facilitate financial crime prevention and decision intelligence sharing, accelerate digital transformation, and grow the value of customer relationships.
Permira brings a growth mindset to BioCatch’s next chapter, with the ability and network to help the Company expand across Continental Europe, where Permira was first established nearly four decades ago. In addition, Permira is excited to back the Company’s exceptional management team and innovative product roadmap, and is committed to further strengthening BioCatch’s global leadership position both organically and inorganically.
“Permira has backed the theme of cybersecurity for several years, and within this, online fraud detection, customer identity and access management markets have become a clear focus. We have tracked BioCatch with enthusiasm for many years, and now having been a shareholder since early 2023, our conviction in the business, its growth potential, its technology leadership, and its management team continues to grow. We’re excited to become the company’s majority shareholder and look forward to a continued successful partnership with Gadi and the BioCatch team as we seek to further accelerate growth and expansion in the years to come,” said Stefan Dziarski, Partner and Co-Head of Permira Growth Opportunities.
Gadi Mazor, CEO of BioCatch, added: “After building a strong partnership with Permira over the last year, we are delighted to welcome them as majority shareholders. The firm’s impressive experience within technology and cybersecurity, combined with their scale, global network, and our close working relationship, has been invaluable since their initial investment. We’re excited to take BioCatch to the next level together. I’d also like to thank Matthew Kinsella from Maverick Ventures and Dewey Awad from Bain Capital for their support over the last four years, which has been key in helping us establish our leadership position in the market.”
“We have had the privilege of partnering with BioCatch over the past four years and worked closely with Gadi and the BioCatch team to develop a long-term strategy to realize the business’s growth potential,” said Dewey Awad, a Partner at Bain Capital. “Together, we drove several key initiatives aimed at augmenting BioCatch’s go-to-market strategy, team, and operations, all with the goal of protecting end-users and their most sensitive transactions. We believe the company is well-positioned to continue its growth journey under Gadi’s leadership and with Permira’s support.”
“At Permira, we are looking to back product-led businesses operating in structurally growing end markets and that have management teams with the ambition to scale and grow their business. We found all of that in BioCatch and were grateful to have the opportunity to make an initial investment in 2023. After a successful first year, we are delighted to take a majority stake in the business as it continues to grow at scale. With the full extent of Permira’s resources and experience at its disposal, we’re excited for what’s to come at BioCatch,” commented Ran Maidan, Senior Adviser and Head of Permira in Israel.
About Permira
Permira is a global investment firm that backs successful businesses with growth ambitions. Founded in 1985, the firm advises funds with total committed capital of approximately €80bn and makes long-term majority and minority investments across two core asset classes, private equity and credit.
The Permira funds have an extensive track record in technology investing, having invested in 50+ companies across SaaS, cybersecurity, digital commerce, fintech and online marketplaces. Permira invested in BioCatch via its Growth Opportunities Fund; its strategy is to back disruptive technology and tech-enabled companies as they scale to the next level. The Permira funds have previously supported and helped scale some of the largest and fastest-growing technology businesses globally, including Genesys, TeamViewer, Zendesk, McAfee, Mimecast, Carta, G2, Sysdig, SonarSource, Mirakl, and others. Permira closed its second Growth Opportunities Fund in December 2021 at $4 billion.
The Permira private equity funds have made approximately 300 private equity investments in four key sectors: Technology, Consumer, Healthcare and Services. Permira employs over 500 people in 15 offices across Europe, the United States and Asia. For more information, visit www.permira.com or follow us on LinkedIn.
About BioCatch
BioCatch stands at the forefront of digital fraud detection, pioneering behavioral biometric intelligence grounded in advanced cognitive science and machine learning. BioCatch analyzes thousands of user interactions to support a digital banking environment where identity, trust, and ease coexist. Today, more than 30 of the world’s largest 100 banks and more than 190 total financial institutions rely on BioCatch Connect™ to combat fraud, facilitate digital transformation, and grow customer relationships.
BioCatch’s Client Innovation Board, an industry-led initiative featuring American Express, Barclays, Citi Ventures, HSBC, and National Australia Bank, collaborates to pioneer creative and innovative ways to leverage customer relationships for fraud prevention. With more than a decade of data analysis, 90 registered patents, and unmatched expertise, BioCatch continues to lead innovation to address future challenges. For more information, visit www.biocatch.com.
Media Contacts
For BioCatch
Mac KingSr. Manager, Corporate Communications, [email protected]+1-206-200-8596
For Permira
James [email protected] +44 774 7006407
Logo – https://mma.prnewswire.com/media/1843699/biocatch_logo_rgb_2x_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/permira-to-acquire-majority-position-in-biocatch-at-1-3bn-valuation-302133942.html

Continue Reading

Trending